| ²é¿´: 1232 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
ɱ½«¹ýȥľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Ò©ÎﻯѧÎÄÏ×һЩ²»¶®µÄÓ¢ÎÄÒâ˼£¬Çó´óÉñ
|
||
|
Creating multifunctional drugs through a hybridization strategy is a well-developed approach in drug design. multifunctional drugs May Offer Better-Than-Additive Effects multifunctional drugsÊǶ๦ÄÜÒ©ÎµÚÒ»´Î¼û Interestingly,although compound 5c was remarkably histone deacetylase 6(HDAC 6) selective at the molecular level, it exhibitedpanHDAC inhibition in a western blot assay, which is likely due to class I HDACs inhibition caused by NO release at the cellular level. Multicenter, randomized, phase II trial of CI-1033, an irreversible pan inhibitor, for previously treated advanced non small-cell lung cancer °ÐµãÓ¢ÎÄËõдǰ¼Ó¸öpan-ǰ׺ʲôÒâ˼£¿panHDAC |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸Ö£´ó0705Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703»¯Ñ§
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ11È˻ظ´
324Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁÏר˶283Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏÓ뻯¹¤306·ÖÕÒµ÷¼Á
ÒѾÓÐ13È˻ظ´
085600£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ8È˻ظ´

ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- ·ÒëEPI: 1690
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ɱ½«¹ýÈ¥: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ¶àл¶àл£¬ÓÐЩ¶«Î÷µÚÒ»´Î½Ó´¥ÅÂÀí½â´íÎó 2015-06-04 22:43:25
ɱ½«¹ýÈ¥: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ¶àл¶àл£¬ÓÐЩ¶«Î÷µÚÒ»´Î½Ó´¥ÅÂÀí½â´íÎó 2015-06-04 22:43:25
|
multifunctional drugsÊǶ๦ÄÜÒ©ÎÊÇͨ¹ýhybridizationÊֶεõ½£¬ËùÒÔ²»Êǵ¥Ò»µÄÒ©ÎÆäЧ¹û±ÈÏà¼Ó×÷ÓÃÒªºÃ¡£ÔÚÒ©ÀíѧÖÐÁ½ÖÖÒ©ÎïÁªºÏÓ¦ÓÃÓÐÏà¼Ó»òÐͬ×÷ÓõĸÅÄîÄã´ó¸ÅÖªµÀ°É£¬ÕâÀïÌáµ½ÁËÏà¼Ó×÷Óã¨Additive Effects£©¡£ panÊÇ·º¡¢È«µÄÒâ˼£¬¾ßÌåµ½ÄãµÄÀý×ÓÖÐÊÇÖ¸HDACµÄ·ºÒÖÖÆ¼Á£¬»òÕß¹âÆ×ÒÖÖÆ¼Á¡£Èç¹ûÄã¶ÔHDACÓÐËùÁ˽âµÄ»¯£¬ËüÓкܶàÀàÐÍ£¬¸÷ÓÐÌØÒìÐÔ£¬¶øpanHDACÔòÄܹ»²»¼ÓÑ¡ÔñµÄÒÖÖÆËùÓÐÀàÐÍ¡£ |
2Â¥2015-06-04 22:40:11














»Ø¸´´ËÂ¥